D.E. Shaw & Co’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,700
Closed -$203K 4570
2024
Q4
$203K Hold
16,700
﹤0.01% 4080
2024
Q3
$281K Hold
16,700
﹤0.01% 4009
2024
Q2
$261K Buy
+16,700
New +$232K ﹤0.01% 3963
2014
Q2
Sell
-22,800
Closed -$384K 4414
2014
Q1
$384K Sell
22,800
-40,000
-64% -$654K ﹤0.01% 3787
2013
Q4
$1.08M Buy
+62,800
New +$1.09M ﹤0.01% 3107

Other funds holding NEOG

D.E. Shaw & Co's NEOG Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Neogen (NEOG) in Q1 2026, closing a stake of 1,040,426 shares — an estimated $7.27M sold.

D.E. Shaw & Co first reported a position in NEOG in Q3 2015 and held it in 29 quarters. The position peaked at $23.5M in Q2 2023. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Neogen position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,040,426 Neogen shares in Q1 2026, an estimated $7.27M.
  • D.E. Shaw & Co first reported a position in Neogen in Q3 2015 and held it in 29 quarters.
  • D.E. Shaw & Co's Neogen position peaked at $23.5M in Q2 2023.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.